Thiazolidinediones
Links shared publicly online about this topic
Thiazolidinediones on #MDlinx
mdlinx.com — “Thiazolidinediones on #MDlinx” View full resource at mdlinx.com
Most Recently Shared on October 22, 2010 at 11:08 pm By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Risk of Cardiovascular Events and All-Cause Mortality in Patients Treated With Thiazolidinediones in a Ma... http://bit.ly/bva0n5 #medicine
Thiazolidinediones on #MDlinx
mdlinx.com — “Thiazolidinediones on #MDlinx” View full resource at mdlinx.com
Most Recently Shared on October 12, 2010 at 6:35 pm By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Safety and tolerability of vildagliptin vs. thiazolidinedione as add-on to metformin in type 2 diabetic p... http://bit.ly/agVDFd #diabetes
Thiazolidinediones on #MDlinx
mdlinx.com — “Thiazolidinediones on #MDlinx” View full resource at mdlinx.com
Most Recently Shared on October 12, 2010 at 3:08 pm By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Safety and tolerability of vildagliptin vs. thiazolidinedione as add-on to metformin in type 2 diabetic patie... http://bit.ly/9r64GN #endo
Endocrinology Article | Thiazolidinediones
mdlinx.com — “A placebo-controlled trial of exenatide twice-daily added to thiazolidinediones alone or in combination with metformin” View full resource at mdlinx.com
Most Recently Shared on November 4, 2010 at 7:59 pm By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
A placebo-controlled trial of exenatide twice-daily added to thiazolidinediones alone or in combination with ... http://bit.ly/cl2SAN #endo
Internal Medicine Article | Thiazolidinediones
mdlinx.com — “A placebo-controlled trial of exenatide twice-daily added to thiazolidinediones alone or in combination with metformin” View full resource at mdlinx.com
Most Recently Shared on November 4, 2010 at 11:24 pm By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
A placebo-controlled trial of exenatide twice-daily added to thiazolidinediones alone or in combinatio... http://bit.ly/apLoNY #medicine
Endocrinology Article | Thiazolidinediones
mdlinx.com — “Antidiabetic prescribing trends and predictors of thiazolidinedione discontinuation following the 2007 rosiglitazone safety alert” View full resource at mdlinx.com
Most Recently Shared on August 15, 2011 at 12:48 pm By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Antidiabetic prescribing trends and predictors of thiazolidinedione discontinuation following the 2007 ros... http://t.co/rd8qSKN #endo
Endocrinology Article | Thiazolidinediones
mdlinx.com — “Thiazolidinediones and Risk of Heart Failure in Patients with or at High Risk of Type 2 Diabetes Mellitus: A Meta-Analysis and Meta-Regression Analysis of Placebo-Controlled Randomized Clinical Trials” View full resource at mdlinx.com
Most Recently Shared on March 31, 2011 at 12:24 pm By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Thiazolidinediones and Risk of Heart Failure in Patients with or at High Risk of Type 2 Diabetes Mellitus:... http://bit.ly/gWURJ1 #endo
Family Medicine Article | Thiazolidinediones
mdlinx.com — “Thiazolidinediones and Risk of Heart Failure in Patients with or at High Risk of Type 2 Diabetes Mellitus: A Meta-Analysis and Meta-Regression Analysis of Placebo-Controlled Randomized Clinical Trials” View full resource at mdlinx.com
Most Recently Shared on March 31, 2011 at 12:41 pm By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Thiazolidinediones and Risk of Heart Failure in Patients with or at High Risk of Type 2 Diabetes Me... http://bit.ly/g7FJah #FamPractice
Internal Medicine Article | Thiazolidinediones
mdlinx.com — “Cardiovascular risk and thiazolidinediones"what do meta-analyses really tell us” View full resource at mdlinx.com
Most Recently Shared on November 2, 2010 at 7:17 pm By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Cardiovascular risk and thiazolidinediones—what do meta-analyses really tell us: Diabetes, Obesity and Me... http://bit.ly/9VGqkY #medicine
Endocrinology Article | Thiazolidinediones
mdlinx.com — “Cardiovascular risk and thiazolidinediones"what do meta-analyses really tell us” View full resource at mdlinx.com
Most Recently Shared on November 3, 2010 at 3:54 am By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Cardiovascular risk and thiazolidinediones—what do meta-analyses really tell us: Diabetes, Obesity and Metabolism http://bit.ly/9Tl2Ib #endo
Thiazolidinediones have a role for appropriate patients
theheart.org — “After 10 years of clinical use of TZDs,” View full resource at theheart.org
Most Recently Shared on October 20, 2009 at 5:16 pm By:
heartwire: Thiazolidinediones have a role for appropriate diabetic patients http://bit.ly/4D7TOO
Thiazolidinediones - Medication for Type 2 Diabetes
diabetes.about.com — “Thiazolidinediones are oral medications that help lower blood sugar in type 2 diabetes. In addition to a healthy diet and exercise, they are another way to control blood sugar levels. Thiazolidinediones currently available in the United States include Actos (pioglitazone), Avandia (rosiglitazone) and a combination drug, Avandamet (rosiglitazone and metformin).” View full resource at diabetes.about.com
Most Recently Shared on May 7, 2010 at 11:21 am By:
Thiazolidinediones: Thiazolidinediones are oral medications that help lower blood sugar in type 2 diabetes. In add... http://bit.ly/9YcppL
Thiazolidinediones for NASH in the balance | Gastroenterology Update
gastroenterologyupdate.com.au — “Patients with NASH taking thiazolidinediones have a modest improvement in histological variables including fibrosis, but at the expense of significant weight gain, an Australian review has found.” View full resource at gastroenterologyupdate.com.au
Most Recently Shared on April 20, 2011 at 6:15 am By:
Gastroenterology Upd Gastroenterology and Medical Publisher
Thiazolidinediones for NASH in the balance http://bit.ly/g4LLRH #gastroenterology
Evidence Mounts Against Thiazolidinediones for Bone Health | diabetes
diabeticlive.com — “Thiazolidinediones are suspected to have an adverse effect on bone density and to increase the risk of bone fracture in patients with diabetes. However, there” View full resource at diabeticlive.com
Most Recently Shared on August 23, 2011 at 1:31 pm By:
Evidence Mounts Against Thiazolidinediones for Bone Health http://t.co/qGxxcXI
Diabetes Drugs: Thiazolidinediones :: Diabetes Self-Management
diabetesselfmanagement.com — “This class of drugs was introduced into practice over a decade ago, but the first thiazolidinedione turned out to be associated with severe side effects. the drug, named troglitazone (brand name rezulin), was introduced into the united states in 1997 and removed from clinical use 3 years later due to concerns about liver damage...” View full resource at diabetesselfmanagement.com
Most Recently Shared on August 28, 2009 at 5:58 pm By:
Diabetes Self-Mgmt Health Site
#diabetes New Blog post by Mark Marino: Diabetes Drugs: Thiazolidinediones http://bit.ly/3Lzqs
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Featuring the top 3 experts for this topic
-
Sandeep Pulim MD
Over 2K medical journal articles & health news summarized and delivered FREE to 35 specialties daily. Oncology, Rheumatology, Cardiology, Neurology, Psychiatry
-
Sandeep Pulim MD
Over 2K medical journal articles & health news summarized and delivered FREE to 35 specialties daily. Oncology, Rheumatology, Cardiology, Neurology, Psychiatry
-
Sandeep Pulim MD
Over 2K medical journal articles & health news summarized and delivered FREE to 35 specialties daily. Oncology, Rheumatology, Cardiology, Neurology, Psychiatry
Advertisement
